oricpharma.com (ORIC) - Cash Funds per Single Share

Corporate emblem and logo of ORIC Corp (ORIC)

ORIC Pharmaceuticals is currently in the clinical trial stage, meaning its budget relies on third-party investments. Fluctuations in cash per share demonstrate a peak in resource availability, where 2.49 records a new level. The company is implementing green chemistry principles and research ethics. The uniqueness of its molecular mechanisms allows ORIC Pharmaceuticals to avoid price wars with manufacturers of similar drugs.

oricpharma.com (ORIC) - Cash per Single Share from 07/04/2022 to 11/20/2026

Comprehensive metric breakdowns and analytics for ORIC Corp (ORIC)

- market price and analyst price targets:
- cash position and cash flow details:
Comprehensive company analysis:ORIC Pharma - ORIC
Flagship merchandise of ORIC Pharma

This indicator measures the available volume of liquid assets per share, allowing for an assessment of financial stability and capital efficiency. By analyzing the cash per share trend, an investor can determine the burn rate, which is critically important for ORIC Pharmaceuticals during the period of intensive clinical trials for CD73 and PLK4 inhibitors.